Reply to: “Prognostic significance of tumor budding in cutaneous squamous cell carcinoma”

2018 ◽  
Vol 79 (1) ◽  
pp. e7
Author(s):  
Jorge Santos-Juanes ◽  
Juan Pablo Rodrigo ◽  
Miriam Gonzalez-Guerrero ◽  
Pablo Martínez-Camblor
Head & Neck ◽  
2012 ◽  
Vol 35 (8) ◽  
pp. 1138-1143 ◽  
Author(s):  
Ardalan Ebrahimi ◽  
Jonathan R. Clark ◽  
Nazanin Ahmadi ◽  
Carsten E. Palme ◽  
Gary J. Morgan ◽  
...  

2012 ◽  
Vol 270 (2) ◽  
pp. 647-653 ◽  
Author(s):  
Aviram Mizrachi ◽  
Tuvia Hadar ◽  
Naomi Rabinovics ◽  
Thomas Shpitzer ◽  
Dan Guttman ◽  
...  

2016 ◽  
Vol 95 (10-11) ◽  
pp. 1-10 ◽  
Author(s):  
Gideon Bachar ◽  
Aviram Mizrachi ◽  
Naomi Rabinovics ◽  
Dan Guttman ◽  
Thomas Shpitzer ◽  
...  

Metastatic cutaneous squamous cell carcinoma (SCC) of the head and neck poses a significant therapeutic challengedue to its aggressive biologic behavior. We conducted a retrospective study of71 patients—58 men and 13 women, aged 28 to 88 years (mean: 71)—who had been treated atour university-affiliated tertiary care medical center for metastatic cutaneous SCCover a 15-year period. In addition to demographic data, we compiled and analyzed information on tumor characteristics, the site and extent of metastasis, treatment, follow-up, and outcome. Among the tumor factors, poorly differentiated carcinoma was an independent predictor of poorer disease-free survival, and olderage was found to be an independent predictor of poorer overall survival. We found no significant difference in disease-free or disease-specific survival among patients with parotid involvement, neck involvement, or both. In our series, the site of nodal involvement appeared to have no prognostic significance in patients with metastatic cutaneous SCC of the head and neck.


Sign in / Sign up

Export Citation Format

Share Document